Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label single-arm study of high capacity process etanercept in rheumatoid arthritis
2013-004569-16Phase 3Completed
- Sponsor
- Pfizer
- Start
- Nov 2014
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of etanercept in rheumatoid arthritis (RA), sponsored by Pfizer. Primary endpoint: Immunogenicity - ADAs through week 24. Started Nov 2014; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2013-004569-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004569-16.